Banner for leaf pages 2

Octreotide

Also known as Sandostatin and Sandostatin Lar

Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.

Source: Wikipedia

Estimated Total Cost: $1745.49 for an average of 21 days supply

What is it prescribed for?

Patients are most commonly prescribed octreotide to treat metastatic cancer, gastrointestinal hemorrhage, blood in stool, and vomiting blood.

What drug interactions are known?

Do not take octreotide if you are taking any of the following:

Critical Interactions


Significant Interactions

Ajax-loader Loading...